PRICE T ROWE ASSOCIATES INC /MD/ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$117
-4.1%
87,113
+27.9%
0.00%
Q2 2023$122
-48.3%
68,108
+12.6%
0.00%
Q1 2023$236
+19.8%
60,466
+4.3%
0.00%
Q4 2022$197
-99.9%
57,955
+10.3%
0.00%
Q3 2022$287,000
+68.8%
52,532
+39.5%
0.00%
Q2 2022$170,000
-12.4%
37,670
+43.2%
0.00%
Q1 2022$194,000
+48.1%
26,298
+28.8%
0.00%
Q4 2021$131,000
-49.8%
20,412
-54.6%
0.00%
Q3 2021$261,000
-93.7%
44,912
-88.7%
0.00%
Q2 2021$4,119,000
-20.6%
399,099
-19.0%
0.00%
-100.0%
Q1 2021$5,186,000
-77.0%
492,955
-66.2%
0.00%
-50.0%
Q4 2020$22,553,000
+7.5%
1,456,901
+1.4%
0.00%0.0%
Q3 2020$20,980,000
-43.5%
1,437,011
-26.7%
0.00%
-60.0%
Q2 2020$37,152,000
+38.7%
1,961,580
+40.6%
0.01%
+25.0%
Q1 2020$26,793,000
+723.4%
1,394,739
+721.6%
0.00%
Q4 2019$3,254,000
+2026.8%
169,759
+1121.7%
0.00%
Q3 2017$153,000
+21.4%
13,8950.0%0.00%
Q2 2017$126,000
-29.2%
13,895
+0.2%
0.00%
Q1 2017$178,000
+36.9%
13,8740.0%0.00%
Q4 2016$130,000
-3.7%
13,8740.0%0.00%
Q3 2016$135,000
+45.2%
13,8740.0%0.00%
Q2 2016$93,000
-25.0%
13,874
-0.2%
0.00%
Q1 2016$124,000
-32.6%
13,9000.0%0.00%
Q4 2015$184,00013,9000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 999,275$37,403,00055.08%
New Leaf Venture Partners, L.L.C. 126,687$4,742,0002.31%
Cormorant Asset Management, LP 385,000$14,411,0002.22%
SECTORAL ASSET MANAGEMENT INC 529,920$19,835,0000.89%
PFM Health Sciences, LP 850,337$31,828,0000.74%
Partner Investment Management, L.P. 16,399$614,0000.25%
Tekla Capital Management LLC 137,766$5,157,0000.24%
Candriam S.C.A. 298,000$11,154,0000.23%
Eventide Asset Management 30,000$1,123,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 81,047$3,034,0000.12%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders